Kanvas Biosciences announced a $48 million Series A funding round, which will support a clinical trial later this year for the company’s lead cancer immunotherapy treatment.
Schwartz Research Fund Visionary Grants for faculty members in the life sciences aims to provide significant assistance for innovative, visionary research that opens an important new line of inquiry.
A new technology allows scientists to map the DNA-binding sites of transcription factors and other regulatory proteins that control gene activity, according to a study led by Weill Cornell Medicine and the New York Genome Center.
A symposium hosted by the Cornell Center for Vertebrate Genomics and the Cornell Center for Immunology attracted early-career researchers and faculty working across genetics, immunology, developmental biology and computational biology.
Researchers at Cornell Tech and Cornell Bowers have created an AI framework that can create “shadow art” – partial line drawings that are completed by the shadow cast from an object – by simply scanning the object.
New research from the Cornell SC Johnson College of Business reveals that pressure to meet earnings targets may push companies to drop weak products and focus on what they do best.
Across partisan lines, Americans broadly believe ultraprocessed foods are addictive and harmful, and support policies that could strengthen safeguards and hold the food industry accountable.
